Transgender women who are on hormone therapy have a twofold higher risk of having venous thromboembolism, compared with cisgender women or men, as well as an up to 90% higher risk of a heart attack or stroke, compared with cisgender women. The findings in the Annals of Internal Medicine were based on medical records for almost 5,000 transgender patients in the Kaiser Health system and more than 97,000 cisgender patients with similar health characteristics and age.
Transgender women on hormone therapy face higher risk of CV problems
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.